https://doi.org/10.1126/science.277.5327.805
M
Mark Nellist
Erasmus MC(NL)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
10.3K
Citations
42
h-index
78
i10-index
Mark Nellist is an academic researcher from Erasmus MC. The author has contributed to research in topics: Tuberous Sclerosis Complex Research & Histiocytic Disorders and Treatments & Polyomavirus and related diseases. The author has an h-index of 42, co-authored 94 publications.
ORCID: 0000-0003-0949-1566Papers by this author
worksIdentification of the Tuberous Sclerosis Gene <i>TSC1</i> on Chromosome 9q34
1997 · Science · 1,659 citations
Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma
2014 · Modern Pathology · 219 citations
https://doi.org/10.1038/modpathol.2014.43
G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
2021 · Cell · 143 citations
https://doi.org/10.1016/j.cell.2020.12.024
Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent <i>TSC1/TSC2</i> biallelic inactivation, and no <i>BRAF</i> mutations
2017 · Oncotarget · 72 citations
https://doi.org/10.18632/oncotarget.20764
Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7)
2016 · Journal of Biological Chemistry · 40 citations
https://doi.org/10.1074/jbc.m115.701870
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
2016 · Oncogene · 39 citations
https://doi.org/10.1038/onc.2016.427
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat